Assignee
XENCOR INC
US174 patents
Top patents by PatentIndex Score
US8367805B2Feb 5, 2013
Fc variants with altered binding to FcRn
XENCOR INC210 citations99
US8039592B2Oct 18, 2011
Optimized Fc variants and methods for their generation
XENCOR INC86 citations99
US7662925B2Feb 16, 2010
Optimized Fc variants and methods for their generation
XENCOR INC349 citations99
US7657380B2Feb 2, 2010
Methods of generating variant antibodies with increased host string content
XENCOR INC169 citations99
US7317091B2Jan 8, 2008
Optimized Fc variants
XENCOR INC872 citations99
US7276585B2Oct 2, 2007
Immunoglobulin variants outside the Fc region
XENCOR INC197 citations99
US9856327B2Jan 2, 2018
Heterodimeric antibodies to CD3 X CD123
XENCOR INC72 citations98
US9701759B2Jul 11, 2017
Heterodimeric proteins
XENCOR INC48 citations98
US9650446B2May 16, 2017
Heterodimeric proteins
XENCOR INC44 citations98
US9605084B2Mar 28, 2017
Heterodimeric proteins
XENCOR INC74 citations98
US9605061B2Mar 28, 2017
Antibodies with modified isoelectric points
XENCOR INC43 citations98
US8383109B2Feb 26, 2013
Optimized Fc variants and methods for their generation
XENCOR INC40 citations98
US8362210B2Jan 29, 2013
Antibody variants with enhanced complement activity
XENCOR INC47 citations98
US7315786B2Jan 1, 2008
Protein design automation for protein libraries
XENCOR INC183 citations98
US6403312B1Jun 11, 2002
Protein design automatic for protein libraries
XENCOR INC321 citations98
US10336818B2Jul 2, 2019
Fc variants with altered binding to FcRn
XENCOR INC47 citations97
US9803023B2Oct 31, 2017
Fc variants with altered binding to FcRn
XENCOR INC62 citations97
US7056695B2Jun 6, 2006
TNF-α variants
XENCOR INC67 citations97
US8802823B2Aug 12, 2014
Optimized Fc variants
XENCOR INC24 citations96
US6514729B1Feb 4, 2003
Recombinant interferon-beta muteins
XENCOR INC104 citations96
US6682923B1Jan 27, 2004
Thermostable alkaliphilic xylanase
XENCOR INC50 citations95
US11225528B2Jan 18, 2022
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC11 citations94
US10793632B2Oct 6, 2020
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
XENCOR INC22 citations94
US10787518B2Sep 29, 2020
Bispecific checkpoint inhibitor antibodies
XENCOR INC15 citations94
US10584176B2Mar 10, 2020
Fc variants with increased affinity for FcγRIIc
XENCOR INC21 citations94
US10550185B2Feb 4, 2020
Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments
XENCOR INC29 citations94
US10526417B2Jan 7, 2020
Heterodimeric antibodies that bind CD3 and CD38
XENCOR INC27 citations94
US10428155B2Oct 1, 2019
Trispecific antibodies
XENCOR INC39 citations94
US10259887B2Apr 16, 2019
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC25 citations94
US10227410B2Mar 12, 2019
Heterodimeric antibodies that bind CD3 and PSMA
XENCOR INC36 citations94
US10184000B2Jan 22, 2019
Optimized Fc variants and methods for their generation
XENCOR INC20 citations94
US9051373B2Jun 9, 2015
Optimized Fc variants
XENCOR INC40 citations94
US11591401B2Feb 28, 2023
Anti-CD28 compositions
XENCOR INC19 citations93
US10501543B2Dec 10, 2019
IL15/IL15Rα heterodimeric Fc-fusion proteins
XENCOR INC13 citations92
US10227411B2Mar 12, 2019
Modulation of T cells with bispecific antibodies and FC fusions
XENCOR INC17 citations92
US10183999B2Jan 22, 2019
Optimized Fc variants and methods for their generation
XENCOR INC10 citations92
US9850320B2Dec 26, 2017
Heterodimeric antibodies to CD3 X CD20
XENCOR INC13 citations92
US9822186B2Nov 21, 2017
Bispecific antibodies that bind to CD38 and CD3
XENCOR INC17 citations92
US9617348B2Apr 11, 2017
Compositions and methods for treating IgE-mediated disorders
XENCOR INC11 citations92
US9353187B2May 31, 2016
Optimized FC variants and methods for their generation
XENCOR INC21 citations92
US9266966B2Feb 23, 2016
Compositions and methods for treating IgE-mediated disorders
XENCOR INC8 citations92
US9221916B2Dec 29, 2015
Compositions and methods for treating IgE-mediated disorders
XENCOR INC12 citations92
US8858937B2Oct 14, 2014
Optimized Fc variants and methods for their generation
XENCOR INC20 citations92
US7610156B2Oct 27, 2009
Methods for rational pegylation of proteins
XENCOR INC29 citations92
US7101974B2Sep 5, 2006
TNF-αvariants
XENCOR INC49 citations92
US9657106B2May 23, 2017
Optimized Fc variants
XENCOR INC13 citations91
US7662367B2Feb 16, 2010
Pharmaceutical compositions for the treatment of TNF-α related disorders
XENCOR INC30 citations90
US7446174B2Nov 4, 2008
Protein based TNF-α variants for the treatment of TNF-α related disorders
XENCOR INC27 citations90
US7244823B2Jul 17, 2007
TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
XENCOR INC49 citations90
US7144987B1Dec 5, 2006
Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders
XENCOR INC23 citations88
Showing the top 50 of 174 patents by PatentIndex Score.